Abstract
The consultation-liaison psychiatrist is consulted fairly often for problems related to pain. This may vary substantially, however, depending on the presence of pain specialists from other disciplines, typically anesthesiology, and the consultation-liaison psychiatrist’s interest in and comfort with pain problems. If the consultation-liaison psychiatrist accept these consults, however, and is considered knowledgeable, requests for help will be frequent.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anooshian, J., Streltzer, J., & Goebert, D. (1999). Effectiveness of a psychiatric pain clinic. Psychosomatics, 40, 226–232.
Ballantyne, J., & Mao, J. (2003). NEJM, 349, 1943–1953.
Boscarino, J. A., Rukstalis, M. R., Hoffman, S. N., Han, J. J., Erlich, P. M., Ross, S., et al. (2011). Prevalence of prescription opioid-use disorder among chronic pain patients: Comparison of the DSM-5 vs. DSM-4 diagnostic criteria. Journal of Addictive Diseases, 30, 185–194.
Breckenridge, J., & Clark, J. D. (2003). Patient characteristics associated with opioid versus nonsteroidal anti-inflammatory drug management of chronic low back pain. The Journal of Pain, 4, 344–350.
Breivik, H., & Rennemo, F. (1982). Clinical evaluation of combined treatment with methadone and psychotropic drugs in cancer patients. Acta Anaesthesiol Scandinavica. Supplementum, 74, 135–140.
Chou, R., Fanciullo, G. J., Fine, P. G., Adler, J. A., Ballantyne, J. C., Davies, P., et al. (2009). Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. The Journal of Pain: Official Journal of the American Pain Society, 10, 113–130.
Compton, P., Charuvastra, V. C., Kintaudi, K., & Ling, W. (2000). Pain responses in methadone-maintained opioid abusers. Journal of Pain and Symptom Management, 20, 237–245.
Dersh, J., Gatchel, R. J., & Polatin, P. (2001). Chronic spinal disorders and psychopathology. Research findings and theoretical considerations. The Spine Journal, 1, 88–94.
Doverty, M., White, J. M., Somogyi, A. A., Bochner, F., Ali, R., & Ling, W. (2001). Hyperalgesic responses in methadone maintenance patients. Pain, 90, 91–96.
Engel, G. L. (1959). Psychogenic pain and pain-prone patient. The American Journal of Medicine, 26, 899–918.
Gorman, A. L., Elliott, K. J., & Inturrisi, C. E. (1997). The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-d-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neuroscience Letters, 14(223), 5–8.
Gourlay, G. K., Cherry, D.A., & Cousins, M. J. (1986). A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain, 25, 297–312.
Hay, J. L., White, J. M., Bochner, F., Somogyi, A. A., Semple, T. J., & Rounsefell, B. (2009). Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients. The Journal of Pain, 10, 316–322.
Hutchinson, M. R., Shavit, Y., Grace, P. M., Rice, K. C., Maier, S. F., & Watkins, L. R. (2011). Exploring the neuroimmunopharmacology of opioids: An integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacological Reviews, 63, 772–810.
Ibuki, T., Dunbar, S. A., & Yaksh, T. L. (1997). Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion. Pain, 70, 125–132.
Jamison, R. N., Kauffman, J., & Katz, N. P. (2000). Characteristics of methadone maintenance patients with chronic pain. Journal of Pain and Symptom Management, 19, 53–62.
Juurlink, D. N., Dhalla, I. A., & Nelson, L. S. (2013). Improving opioid prescribing: The New York City recommendations. JAMA, 309, 879–880.
Katz, M. (2010). Long-term opioid treatment on nonmalignant pain: A believer loses his faith. Archives of Internal Medicine, 170, 1422–1423.
King, T., Gardell, L. R., Wang, R., Vardanyan, A., Ossipov, M. H., Malan, T. P., Jr., et al. (2005). Role of NK-1 neurotransmission in opioid-induced hyperalgesia. Pain, 116, 276–288.
Marks, R. M., & Sachar, E. J. (1973). Undertreatment of medical inpatients with narcotic analgesics. Annals of International Medicine, 78, 173–181.
Martin, B. I., Deyo, R. A., Mirza, S. K., Turner, J. A., Comstock, B. A., Hollingworth, W., et al. (2008). Expenditures and health status among adults with back and neck problems. JAMA, 299, 656–664.
Mercadante, S., Sapio, M., Serretta, R., & Caligara, M. (1996). Patient-controlled analgesia with oral methadone in cancer pain: preliminary report. Annals of Oncology, 7, 613–617.
MMWR. (2005). Increase in poisoning deaths caused by non-illicit drugs-Utah. Morbidity and Mortality Weekly Report, 54(2), 33–36.
Nestler, E. J. (2001). Molecular neurobiology of addiction. The American Journal on Addictions, 10, 201–217.
Newman, R. I., Seres, J. L., Yospe, L. P., & Garlington, B. (1978). Multidisciplinary treatment of chronic pain: Long-term follow-up of low-back pain patients. Pain, 4, 283–292.
O’Neill, W. M., Hanks, G. W., Simpson, P., Fallon, M. T., Jenkins, E., & Wesnes, K. (2004). The cognitive and psychomotor effects of morphine in healthy subjects: A randomized controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo. Pain, 85, 209–215.
Paulozzi, L. J., & Ryan, G. W. (2006). Opioid analgesics and rates of fatal drug poisoning in the United States. American Journal of Preventive Medicine, 31, 506–511.
Portenoy, R. K., & Foley, K. M. (1986). Chronic use of opiod analgesics in nonmalignant pain: Report of 38 cases. Pain, 25, 171–186.
Rosenblum, A., Joseph, H., Fong, C., Kipnis, S., Cleland, C., & Portenoy, R. K. (2003). Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA, 289, 2370–2378.
Schreiber, S., Backer, M. M., Weizman, R., & Pick, C. G. (1997). Augmentation of opioid induced antinociception by the atypical antipsychotic drug risperidone in mice. Neuroscience Letters, 228, 25–28.
Stinus, L., Allard, M., Gold, L., & Simmonet, G. (1995). Changes in CNS neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment. Peptides, 16, 1235–1241.
Streltzer, J. (1980). Treatment of iatrogenic drug dependence in the general hospital. General Hospital Psychiatry, 2, 262–266.
Streltzer, J. (1994). Chronic pain and addiction. In H. Leigh (Ed.), Consultation-liaison psychiatry: 1990 and beyond (pp. 43–51). New York: Plenum.
Streltzer, J. (2011). Chapter 6, assessment of pain and psychiatric comorbidities. In M. Ebert & R. Kerns (Eds.), Behavioral and psychopharmacologic pain management (pp. 82–93). Cambridge, UK: Cambridge University Press.
Streltzer, J., Eliashof, B. A., Kline, A. E., & Goebert, D. (2000). Chronic pain disorder following physical injury. Psychosomatics, 41, 227–234.
Streltzer, J., & Wade, T. C. (1981). Cultural factors in the undertreatment of postoperative pain. Psychosomatic Medicine, 43, 397–403.
Streltzer, J. (2001). Pain Management in the Opioid Dependent Patient. Current Psychiatry Reports, 3, 489–496.
Streltzer, J., & Johansen, L. (2006). Prescription drug dependence and evolving beliefs about pain management. American Journal of Psychiatry,163, 594–598.
Sullivan, M., Edlund, M. J., Zhang, L., Unutzer, J., & Wells, K. B. (2006). Association between mental health disorders, problem drug use, and regular prescription opioid use. Archives of Internal Medicine, 166, 2087–2093.
Sullivan, M. D., Von Korff, M., Banta-Green, C., Merrill, J. A., & Saunders, K. (2010). Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain. Pain, 149, 345–353.
The American Academy of Pain Medicine, The American Pain Society. (1997). The use of opioids for the treatment of chronic pain: A consensus statement from the American Academy of Pain Medicine and the American Pain Society. The Clinical Journal of Pain, 13, 6–8.
The DAWN Report (2004). Narcotic analgesics, 2002 update
Vanderah, T. W., Gardell, L. R., Burgess, S. E., Ibrahim, M., Dogrul, A., Zhong, C. M., et al. (2000). Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. The Journal of Neuroscience, 20, 7074–7079.
Verebely, K., Volavka, J., Mulé, S., & Resnick, R. (1975). Methadone in man: Pharmacokinetic and excretion studies in acute and chronic treatment. Clinical Pharmacology and Therapeutics, 18, 180–190.
Von Korff, M., & Commentary on Boscarino. (2010). Understanding the spectrum of opioid abuse, misuse and harms among chronic opioid therapy patients. Addiction, 105, 1783–1784.
Von Korff, M., Crane, P., Lane, M., Miglioretti, D. L., Simon, G., Saunders, K., et al. (2005). Chronic spinal pain and physical-mental comorbidity in the United States: Results from the national comorbidity survey replication. Pain, 113, 331–339.
Von Korff, M., & Deyo, R. A. (2004). Potent opioids for chronic musculoskeletal pain: Flying blind? Pain, 109, 207–209.
Von Korff, M., Kolodny, A., Deyo, R. A., & Chou, R. (2011). Long-term opioid therapy reconsidered. Annals of Internal Medicine, 155, 325–328.
White, J. (2004). Pleasure into pain: The consequences of long-term opioid use. Addictive Behaviors, 29, 1311–1324.
Wolff, B., Burns, J. W., Quartana, P. J., Lofland, K., Bruehl, S., & Chung, O. Y. (2008). Pain catastrophizing, physiological indexes, and chronic pain severity: Tests of mediation and moderation models. Journal of Behavioral Medicine, 31(2), 105–114.
Xie, J., Herman, D., Stiller, C., Gardell, L., Ossipov, M., Lai, J., et al. (2005). Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. The Journal of Neuroscience, 25, 409–416.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Hoyle Leigh & Jon Streltzer
About this chapter
Cite this chapter
Streltzer, J. (2015). Chronic Pain (Somatic Symptom Disorder with Predominant Pain). In: Leigh, H., Streltzer, J. (eds) Handbook of Consultation-Liaison Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-319-11005-9_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-11005-9_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11004-2
Online ISBN: 978-3-319-11005-9
eBook Packages: MedicineMedicine (R0)